Michael Goggins
Tracked across 1 events · 21 articles · First seen Jul 16, 2026 · Last active Aug 07, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
A phase 1 clinical trial of mKRAS-VAX, an investigational vaccine targeting six common KRAS mutations, demonstrated safety and durable immune responses in 18 of 20 high-risk individuals for pancreatic ductal adenocarcinoma (PDAC). The vaccine, developed…
Impact: Co-author and professor at Johns Hopkins; contributed to analysis of cyst changes and immune responses.
Jul 16, 2026 · 21 articles
ERGEN INTELLIGENCE
Track Michael Goggins live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard